Hitomi Oki

Statistics

Publications

Citations

454

H-Index

Active since

2010

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Hitomi Oki is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicinal chemistry, antipsychotic pharmacology, and 5-hydroxytryptamine 1a receptor agonists.

Publications per year

2010–2019

Publications

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Takeo Ishiyama et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 433 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity

Michiko WATANABE, Takamitsu Sasaki, Jun‐ichi Takeshita et al. · Toxicology and Applied Pharmacology · 2019 · 11 citations

Medicine, Pharmacology, Toxicology +16

Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT1A receptor agonistic activity

Hidefumi Yoshinaga, Tomoaki Nishida, Izumi Sasaki et al. · Bioorganic & Medicinal Chemistry · 2018 · 10 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–3 of 3